Nivolumab Versus Sorafenib in Advanced Hepatocellular Carcinoma (checkmate 459): a Randomised, Multicentre, Open-Label, Phase 3 Trial
SSRN Electronic Journal(2021)
Key words
Hepatocellular Carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined